Evidence map›Paper›PMID 31900120›Full record

ReviewBMC pediatrics2020

A comprehensive overview of the cystic fibrosis on the island of São Miguel (Azores, Portugal).

Joana Rosa, Patrícia Gaspar-Silva, Paula Pacheco, Conceição Silva, Cláudia C Branco, Barbara S Vieira, Alexandra Carreiro, Juan Gonçalves, Luisa Mota-Vieira

Open access · goldAbstract readReview
In one paragraph

Review in BMC pediatrics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Joana RosaPediatric Department, Hospital do Divino Espirito Santo de Ponta Delgada EPER, 9500-782 Ponta Delgada São Miguel Island, Azores, Portugal. JR890330@azores.gov.pt.ORCID 0000-0002-1032-0695
Patrícia Gaspar-SilvaPediatric Department, Hospital do Divino Espirito Santo de Ponta Delgada EPER, 9500-782 Ponta Delgada São Miguel Island, Azores, Portugal.
Paula PachecoCentre for Human Genetics, Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal.
Conceição SilvaCentre for Human Genetics, Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal.
Cláudia C BrancoMolecular Genetics and Pathology Unit, Hospital do Divino Espirito Santo de Ponta Delgada EPER, São Miguel Island, Azores, Portugal.
Barbara S VieiraUnidade de Saúde Pública da Unidade de Saúde da Ilha de São Miguel, São Miguel Island, Azores, Portugal.
Alexandra CarreiroPneumology Department, Hospital do Divino Espirito Santo de Ponta Delgada EPER, São Miguel Island, Azores, Portugal.
Juan GonçalvesPediatric Department, Hospital do Divino Espirito Santo de Ponta Delgada EPER, 9500-782 Ponta Delgada São Miguel Island, Azores, Portugal.
Luisa Mota-VieiraMolecular Genetics and Pathology Unit, Hospital do Divino Espirito Santo de Ponta Delgada EPER, São Miguel Island, Azores, Portugal.
Hospital do Divino Espírito Santo · PTNational Institute of Health Dr. Ricardo Jorge · PTUniversity of Lisbon · PTAdministração Regional de Saúde de Lisboa e Vale do Tejo · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEarly diagnosis and treatment are improving significantly the quality of life of patients with cystic fibrosis (CF). This recessive disease is caused by a great variability of mutations in the CF transmembrane conductance (CFTR) gene, whose spectrum and frequency can be different across populations.

methodsWe performed a retrospective cross-sectional study of CF patients from the island of São Miguel (Azores, Portugal) through a clinical, genealogical, genetic and epidemiological investigation. The clinical course of patients was analyzed as a whole and according to their genotype.

resultsWe identified 14 CF patients within a 23-year period, corresponding to a cumulative incidence of 1:3012 births, being three of them born from consanguineous unions. Genetic analysis revealed three CFTR genotypes: p.[Ser4Ter];[Gln1100Pro] was present in one patient with a less severe phenotype (1/14); c.[120del23];p.[Phe508del], a very rare one (2/14); and p.[Phe508del];[Phe508del] in the remaining patients (11/14). Clinically, respiratory infections (8/14) and growth failure (6/14) were the most common initial manifestations. All patients presented pancreatic dysfunction, with 21.4 and 100% of them showing endocrine and exocrine insufficiency, respectively. As expected, patients with severe phenotype were homozygous for p.Phe508del and had the lowest value of body mass index.

conclusionsThe present study demonstrated that São Miguel Island has an increased incidence of CF when compared to recent Portuguese data (1:7500 live births). It also allowed a comprehensive overview of CF in São Miguel, improving medical practice along with genetic counselling and creating opportunities for genotype-targeted therapies.

Indexed as

Cystic FibrosisAzoresCross-Sectional StudiesCystic Fibrosis Transmembrane Conductance RegulatorGenotypeHumansMutationPortugalQuality of LifeRetrospective StudiesCystic Fibrosis Transmembrane Conductance RegulatorCystic fibrosisCystic fibrosis Transmembrane conductance regulatorGenotype-phenotype analysis

Identifiers

PMID31900120
PMCPMC6942372
OpenAlexW2998093949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.